- Investing Ideas
- Swiss Pharmaceuticals & Biotech Mid-Large Cap Stocks
Swiss Pharmaceuticals & Biotech Mid-Large Cap Stocks
Results
14
Mid-Large Cap Stocks
14 companies
Roche Holding
Market Cap: CHF 266.5b
Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
ROP
CHF 334.20
7D
-0.7%
1Y
29.3%
Novartis
Market Cap: CHF 228.8b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NOVN
CHF 125.00
7D
0.6%
1Y
35.4%
Tecan Group
Market Cap: CHF 2.3b
Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.
TECN
CHF 180.00
7D
-1.6%
1Y
12.0%
Bachem Holding
Market Cap: CHF 5.3b
Provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide.
BANB
CHF 71.15
7D
-4.9%
1Y
22.4%
Sandoz Group
Market Cap: CHF 28.4b
Develops, manufactures, and markets generic and biosimilars worldwide.
SDZ
CHF 65.74
7D
-3.0%
1Y
43.7%
Cosmo
Market Cap: CHF 1.0b
A life sciences company, develops and manufactures pharmaceuticals and contracts for gastroenterology, dermatology, and health tech in Ireland and internationally.
COPN
CHF 63.40
7D
-1.4%
1Y
3.6%
SKAN Group
Market Cap: CHF 1.3b
Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.
SKAN
CHF 56.30
7D
-0.9%
1Y
-23.9%
Galderma Group
Market Cap: CHF 40.5b
Operates as a dermatology company worldwide.
GALD
CHF 172.50
7D
-0.2%
1Y
35.5%
Kuros Biosciences
Market Cap: CHF 818.4m
Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.
KURN
CHF 20.74
7D
-3.3%
1Y
-27.4%
Lonza Group
Market Cap: CHF 39.7b
Operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.
LONN
CHF 567.80
7D
-3.1%
1Y
-0.4%
Dottikon ES Holding
Market Cap: CHF 3.7b
Manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical industries.
DESN
CHF 266.50
7D
-0.7%
1Y
-16.7%
Idorsia
Market Cap: CHF 1.5b
A biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland, the United States, Japan, Europe, China, and Canada.
IDIA
CHF 5.90
7D
-4.8%
1Y
101.4%
Siegfried Holding
Market Cap: CHF 3.2b
Engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide.
SFZN
CHF 73.75
7D
1.7%
1Y
-17.5%
PolyPeptide Group
Market Cap: CHF 1.4b
Operates as a contract development and manufacturing company in Europe, the United States, Asia Pacific, and internationally.
PPGN
CHF 41.75
7D
-9.2%
1Y
89.3%